Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Plenary vote on the EU taxonomy Complementary Climate Delegated Act

Ahead of tomorrow’s vote in the European Parliament on the Complementary Climate Delegated Act of the EU taxonomy (cDA), the Club of Rome outlines our expectations and analysis ahead of the vote on the objection resolution, against the inclusion of gas and nuclear in the “green” taxonomy framework.Context and expectations · On Wednesday 6 July, Members of the European Parliament will vote in a plenary on the motion for resolution objecting to the Complementary Climate Delegated Act (CDA) under the Taxonomy Regulation, against the inclusion of gas and nuclear in the “green” taxonomy

Terveystalo grows in well-being services by acquiring Kunnon Syke Oy

Terveystalo Press Release 5 July 2022 at 15:00 EEST   Terveystalo continues to grow its offering in well-being services by acquiring Kunnon Syke Oy.   Kunnon Syke Oy, founded in 1981, offers physiotherapy, masseur, naprapathy, chiropractic, and podiatry services, as well as functional rehabilitation services at its seven clinics. Kunnon Syke Oy employs 16 professionals and the company's revenue in the financial year 08/2021 was approximately EUR 1.02 million.   “Kunnon Syke Oy will become part of Terveystalo, which is a leading player in health services in terms of both

Pharmacolog France wins yet another order

Pharmacolog France has received an order for DrugLog™ to L’Institut du Cancer de Montpellier. The system will be used for the final quality control of chemotherapy preparations at the hospital pharmacy.Pharmacolog France SARL has received an order for one DrugLog™ system to be placed at L’Institut du Cancer de Montpellier (ICM) in Montpellier, France. This is the third DrugLog™ order received during the last three weeks by Pharmacolog France. ICM belongs to the Unicancer Group and has been ranked as one of the World’s Best Specialized Hospitals 2021 in the oncology category by Newsweek.

Lagercrantz acquires Stegborgs El-evator AB

Lagercrantz Group has today acquired all the shares in Stegborgs El-evator AB.Stegborgs El-evator offers products and solutions for renovation and rebuilding of elevators. The offer includes a proprietary control system, emergency telephones and complete elevator materials and solutions. Primary customers are service and installation companies, with end customers such as housing society and real estate companies. Stegborgs El-evator is located in Strängnäs and has a turnover of just over SEK 60 million with good profitability. “Stegborgs El-evator has a strong position in the renovation

IFS acquires ULTIMO

· IFS extends leadership in the EAM software space with ULTIMO’s impressive product capabilities and customer base, and expert team. · ULTIMO’s SaaS offering differentiated by fast time to value, high levels of flexibility and configurabilityLondon, July 5, 2022 – IFS , announces it has signed a definitive agreement to purchase Ultimo Software Solutions, the Netherlands based provider of cloud Enterprise Asset Management (EAM) software. ULTIMO has been widely acknowledged for building a strong reputation for the completeness, flexibility, and configurability of its

Wärtsilä supplies battery to Pivot Power as part of cutting-edge Energy Superhub Oxford project

Wärtsilä Corporation, Trade press release, 5 July 2022 at 2.30 PM EESTThe technology group Wärtsilä has supplied a 50 MW / 50 MWh lithium-ion battery to Pivot Power, part of EDF Renewables, who have developed a cutting-edge hybrid battery site in Oxford, UK. The hybrid battery system, which was officially launched today at the opening of Energy Superhub Oxford (ESO), will play an essential role in the UK’s shift to renewables. The hybrid battery combines Wärtsilä’s 50 MW / 50 MWh lithium-ion battery with Invinity’s 2 MW / 5 MWh vanadium-flow battery. The system will be controlled and

Lehto Group Plc: Managers’ Transactions

Lehto Group PlcManagers' transactions5 July 2022 at 2.30 p.m. (EET)Lehto Group Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Tero KarislahtiPosition: Other senior manager Issuer: Lehto Group OyjLEI: 743700YEHY9I3ZDHNX66Notification type: INITIAL NOTIFICATIONReference number: 17685/5/4____________________________________________ Transaction date: 2022-07-04Venue: OFF-EXCHANGE LIIKETOIMET (XOFF)Instrument type: SHAREISIN: FI4000081138Nature of the transaction: RECEIPT OF A SHARE-

CORRECTION: Change in number of shares and votes

On July 4, 2022, Eltel AB (publ) (“Eltel”) published a press release titled "Change in number of shares and votes". It has been noted that the press release contained an incorrect indication of the number of C-shares and ordinary shares in the company as of July 4, 2022. A corrected wording with the correct number of shares and votes can be found below.Eltel AB (publ) (“Eltel”) has during June 2022 converted 87,700 class C shares to ordinary shares pursuant to the company’s articles of association. Prior to the conversion, the total number of outstanding shares in Eltel amounted to 158,

Invitation to the Volvo Group report on the second quarter 2022

The Volvo Group report for the second quarter 2022 will be published on Juli 19, 2022, at 7.20 a.m. CEST. There will be a conference call for press and analysts starting at 9.00 a.m. CEST.An online presentation of the report, followed by a question-and-answer session, will be broadcast at 9.00 a.m. CEST. The Volvo Group will be represented by President and CEO Martin Lundstedt and CFO Tina Hultkvist. To listen to the online conference, please log in about ten minutes prior to the start. Link to login:https://services.choruscall.de/DiamondPassRegistration/register?

BioStock: Doubled sales and an improved position for PHI

In the year-end report for 2021/2022, Phase Holographic Imaging highlights the increased sales, the investment in regenerative medicine and the patent awarded for synthetic antibodies. The company reports doubled sales and is ready to deliver the new addition to the company’s product range during the autumn.Read the full article at biostock.se: https://www.biostock.se/en/2022/07/doubled-sales-and-an-improved-position-for-phi/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Invitation to presentation of Q2 2022 financial results

Viaplay Group, the international streaming challenger, will publish its Q2 2022 financial results at 07:30 CET on Thursday 21 July. Teleconference and webcastA teleconference and webcast will be held at 09:00 CET on Thursday 21 July, hosted by Anders Jensen, President & CEO; Åsa Regen Jansson, Acting CFO; and Matthew Hooper, Chief Corporate Affairs Officer. The presentation will be streamed on the following link: https://edge.media-server.com/mmc/p/bho79sne Dial-in informationIn order to participate, please call: Sweden: +46 (0) 8 505 100 30UK:  +44 (0) 1 212 818 004

Enersense receives a framework agreement regarding maintenance projects for Sweden’s national grid

Enersense International PlcPress release 5 July 2022 at 1:00 p.m.A Latvian subsidiary of Enersense International Plc, a creator of zero-emission energy solutions, Empower SIA, which operates in the business area of International Operations, has signed a framework agreement with Svenska kraftnät, Sweden’s national grid operator, regarding the revision and renewal measures of approximately 30 per cent of the national grid in Sweden during an eight-year period. "The agreement is important to us for several reasons. Among other things, the signed agreement strengthens our position in the

Invitation to the presentation of Alimak Group´s report for the second quarter 2022

Alimak Group’s interim report for January-June 2022 will be published on July 19, 2022 at 08:00 CET.A telephone conference for investors, analysts and financial media will be held at 10.00 CET on Tuesday July 19, 2022. CEO Ole Kristian Jødahl and CFO Thomas Hendel will present and comment on the report. The presentation, held in English, can also be followed via audiocast. To participate by phone – please call: SE: +46 8 505 246 42 UK: +44 20 8610 3526 US: +1 (646) 307 1951 If needed, please state conference-ID 9546728 or Alimak Group Link to audiocast: https://streams.

Elomatic expands its business in Germany with a new maritime technology subsidiary

Elomatic Oy has established a subsidiary in Wismar, Germany, focusing on ship design and offshore wind power structures. The new subsidiary, called Elomatic Maritime Technologies, will enhance Elomatic's capacity to provide excellence to shipping companies, operators, and shipyards worldwide. There are many experienced professionals in the area due to the closure of the MV Werften shipyard.On June 21st, Elomatic Oy established a new design and consulting subsidiary in Germany called Elomatic Maritime Technologies. It will take on challenging work in the area of ship design and offshore

Invitation to presentation of NCC’s interim report for the second quarter 2022

NCC’s interim report for the second quarter and first half of 2022 will be published on Tuesday July 19, 2022. The report will be distributed and available on NCC’s website ncc.com/ir at about 7:10 a.m. CEST.Media and capital market representatives are invited to an audiocast on the same day at 9:00 a.m. CEST where CEO Tomas Carlsson and CFO Susanne Lithander will present the interim results. The presentation will be held in English and can be followed online and by phone, as below, where it is also possible to ask questions.   Presentation material will be published at ncc.com/ir on

Repurchase of NCC Series B shares in week 26, 2022

During the period June 27 – July 1, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 408,171 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

Ovzon receives order from Gomedia Satcom and expands partnership for development of new applications

Ovzon has received an order from its Italian partner Gomedia Satcom. The order includes services and capacity on one of Ovzon's steerable satellite beams. The 6-month contract, valued at 0.2 MUSD, will start on July 5, 2022.Ovzon has already today a very fruitful collaboration with its Italian partner Gomedia Satcom. Since early 2022, Ovzon provides SATCOM-as-a-Service to the Italian Fire and Rescue Service with unprecedented levels of performance, agility, and resiliency. The new order includes services and capacity on one of Ovzon's steerable beams but is also the starting point of an

BioStock: Spago Nanomedical progresses towards clinical phase with Tumorad

Just before mid-year, Lund-based Spago Nanomedical announced that the company raised 58.4 MSEK in the completed capital round. The proceeds give the company the resources to maintain the pace in its two projects – SpagoPix in cancer diagnostics and Tumorad, in which it is developing a new radionuclide cancer treatment. BioStock reached out to CEO Mats Hansen for comments on recent events and what awaits in the coming six months.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2022/07/spago-nanomedical-progresses-towards-clinical-phase-

IAR Systems enable innovation in Automotive, providing full support for Renesas RH850

IAR Systems is proud to announce its new v3.10 of IAR Embedded Workbench, and IAR Build Tools for Renesas RH850, a world-leading device often used to create groundbreaking solutions in the next generation vehicles by the automotive industry globally.Uppsala, Sweden—July 5, 2022 — The growing complexity of automotive applications require real-time control without sacrificing performance. This can only be achieved with modern multi-core RH850 Automotive MCUs 

Terveystalo H1/2022 result webcast and conference call on 19 July 2022

Terveystalo Press Release 5 July 2022 at 11:00 EEST   Terveystalo Plc will publish its 2022 half-year report on Tuesday 19 July, 2022 at 9:00 EEST. Materials will be available soon after publication on Terveystalo’s IR website.   Terveystalo will arrange a result webcast and conference call in English on the same day, starting at 10:30 EEST. You can watch the webcast online at: https://terveystalo.videosync.fi/2022-q2-results 

Invitation to AAK’s presentation of the second quarter 2022 on July 19

In connection with the release of AAK’s Interim report for the second quarter 2022, we invite you to a press and analyst conference to be held on Tuesday, July 19, 2022, at 1 p.m. CET. The conference will be chaired by Johan Westman, President and CEO, and Tomas Bergendahl, CFO. The presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only.   To follow the conference by phone, please use one of the numbers below, followed by pin code 5685569:SE: +46 8 505 163 86UK: +44 20 319 84884US:

BioStock: Pila Pharma initiates toxicological studies

Malmö company Pila Pharma is in full swing with preparations for a phase IIb study with the drug candidate XEN-D0501. But before the study can initiated, the company needs to conduct a three-month preclinical toxicological study. The company has now announced that the toxicological study has started. BioStock contacted Pila Pharma’s CEO Dorte X Gram to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2022/07/pila-pharma-initiates-toxicological-studies/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

CPT PLA Code for the IMMray™ PanCan-d test approved

LUND, SWEDEN – Immunovia AB (Nasdaq Stockholm: IMMNOV) announced, that Immunovia, Inc., its American subsidiary, has recently received approval for a Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) code from the American Medical Association (AMA) for the IMMray™ PanCan-d test. The code will be effective on October 1, 2022. Immunovia is currently in process with the Centers of Medicare & Medicaid Services (CMS) to establish payment for IMMray™ PanCan-d with this PLA code which will be included in the 2023 CMS Clinical Lab Fee Schedule.   “We are very pleased

There are no items matching the current filter
There are no more items matching the current filter
Back to top